Vesey Street Capital Partners Welcomes New Leaders to Advisory Board for Growth in Healthcare Investments
Vesey Street Capital Partners Expands Strategic Advisory Board
In a noteworthy development for the healthcare investment sector, Vesey Street Capital Partners (VSCP) has announced the addition of three experienced leaders to its Strategic Advisory Board. This initiative reflects the firm's commitment to enhancing its portfolio of lower middle-market healthcare service companies. The new members—Glenn Eisenberg, Todd Gustin, and Chip Kahn—bring a wealth of knowledge and expertise that will be instrumental in steering the firm’s strategic direction.
VSCP's Strategic Advisory Board Chairman, Dave King, expressed enthusiasm regarding the appointments: “We are thrilled to welcome Glenn, Todd, and Chip to our strategic advisory board. Their diverse backgrounds, expertise, and networks will be invaluable as we continue to advance our objectives in the healthcare sector.”
Profiles of the New Board Members
Glenn Eisenberg
Glenn Eisenberg is a seasoned executive with a stellar career marked by his tenure as the Executive Vice President and Chief Financial Officer at Labcorp, a global leader in life sciences with a market capitalization of approximately $13 billion. In this role, he dove deep into finance, operations, and corporate governance, driving the company through significant transformations. Prior to Labcorp, Glenn held senior positions at The Timken Company and United Dominion Industries. His extensive background in managing and overseeing complex transactions positions him as a highly knowledgeable advisor to VSCP.
Todd Gustin
Elevating the dynamic of the board is Todd Gustin, who has spearheaded Genoa Healthcare as its Chief Executive Officer. Recognized as a leading provider of pharmacy services focused on behavioral health, Todd’s leadership spans over 25 years within the healthcare landscape. His remarkable track record includes previous roles at Optum, where he navigated significant growth and transformation strategies. Todd's accolades, including his recognition as one of the Top 50 Healthcare Technology CEOs of 2024, underscore his innovative approach to achieving better patient outcomes while simultaneously reducing costs.
Chip Kahn
Chip Kahn brings an unparalleled depth of experience in health policy. Serving as President and CEO of the Federation of American Hospitals since 2001, he is influential in shaping national healthcare legislation. Consistently recognized in Modern Healthcare's list of
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.